Generic Drugs – Decreasing Costs and Room for Increased Number of Kidney Transplantations
By: Goce Spasovski
References
- 1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999; 341(23): 1725-1730.
- 2. Barnieh L, Yilmaz S, McLaughlin K, et al. The cost of kidney transplant over time. Prog Transplant. 2014; 24(3): 257-62.
- 3. James A, Mannon RB. The Cost of Transplant Immunosuppressant Therapy: Is This Sustainable? Curr Transplant Rep. 2015; 2(2): 113-121.
- 4. Allard J, Fortin MC. Is it ethical to prescribe generic immunosuppressive drugs to renal transplant patients? Can J Kidney Health Dis. 2014; 1: 23.
- 5. Generic Drugs. Center for Drug evaluation and Research, U.S. Food and Drug Administration. [Cited 2015 July 13rd] Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm127615.pdf.
- 6. Generic Drugs. World Health Organisation. [Cited 2015 July 13rd] Available from: http://www.who.int/trade/glossary/story034/en/.
- 7. Generic Drugs. The Free Dictionary. [Cited 2015 July 13rd] Available from: http://medicaldictionary.thefreedictionary.com/Drugs%2c+generic.
- 8. EFPIA. The Pharmaceutical Industry in Figures, key data 2014. [Cited 2015 July 13rd] Available from: http://www.efpia.eu/uploads/Figures_2014_Final.pdf.
- 9. Meredith P. Bioequivalence and other unresolved issues in generic drug substitution. Clin Ther. 2003; (11): 2875-90.
- 10. Gondos A, Döhler B, Brenner H, Opelz G. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation. 2013; 95(2): 267-74.
- 11. Roodnat JI, Hilbrands LB, Hené RJ, et al. 15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation. Transplantation. 2014; 98(1): 47-53.
- 12. Gaynor JJ, Ciancio G, Guerra G, et al. Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study. Transplantation. 2014; 97(9): 925-33.
- 13. Couzi L, Moulin B, Morin MP, et al. Factors predictive of medication nonadherence after renal transplantation: a French observational study. Transplantation. 2013; 95(2): 326-32.
- 14. Tamargo J, Le Heuzey JY, Mabo P. Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide. Eur J Clin Pharmacol. 2015; 71(5): 549-567.
- 15. Verbeeck RK, Musuamba FT. The revised EMA guideline for the investigation of bioequivalence for immediate release oral formulations with systemic action. J Pharm Pharm Sci. 2012; 15(3): 376-88.
- 16. Lionberger R, Jiang W, Huang SM, Geba G: Confidence in generic drug substitution. Clin Pharmacol Ther. 2013; 94: 438-440.
- 17. van Gelder T, Gabardi S. Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs. Transpl Int. 2013; 26: 771-7.
- 18. Waiser J, Slowinski T, Brinker-Paschke A, et al. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function. Nephrol Dial Transplant. 2002; 17(7): 1310-7.
- 19. Spasovski G, Masin-Spasovska J, Ivanovski N. Do we have the same clinical results with Neoral and Equoral treatment in kidney transplant recipients? A pilot study. Transpl Int. 2008; 21(4): 392-4.
- 20. Borra LC, Roodnat JI, Kal JA, et al. High withinpatient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation. Nephrol Dial Transplant. 2010; 25(8): 2757-63.
- 21. Sellarés J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant. 2012; 12(2): 388-99.
- 22. Vítko S, Ferkl M. Interchangeability of ciclosporin formulations in stable adult renal transplant recipients: comparison of Equoral and Neoral capsules in an international, multicenter, randomized, open-label trial. Kidney Int Suppl. 2010; (115): S12-6.
- 23. Alloway RR, Sadaka B, Trofe-Clark J, et al. A Randomized Pharmacokinetic Study of Generic Tacrolimus Versus Reference Tacrolimus in Kidney Transplant Recipients. Am J Transplant. 2012; 12(10): 2825-2831.
- 24. Melilli E, Crespo E, Sandoval D, et al. De novo use of a generic formulation of tacrolimus versus reference tacrolimus in kidney transplantation: evaluation of the clinical results, histology in protocol biopsies, and immunological monitoring. Transpl Int. 2015; 28(11): 1283-90.
- 25. Molnar AO, Fergusson D, Tsampalieros AK, et al. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ. 2015; 350: h3163.
- 26. Johnston A. Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation. Eur J Hosp Pharm Sci Pract. 2013; 20(5): 302-307.
- 27. Harrison JJ, Schiff JR, Coursol CJ, et al. Generic immunosuppression in solid organ transplantation: a Canadian perspective. Transplantation. 2012; 93: 657-665.
- 28. Alloway RR, Isaacs R, Lake K, et al. Report of the American Society of Transplantation conference on immunosuppressive drugs and the Use of generic immunosuppressants. Am J Transplant. 2003; 3: 1211-1215.
- 29. Gordon EJ, Prohaska TR, Sehgal AR. The financial impact of immunosuppressant expenses on new kidney transplant recipients. Clin Transplant. 2008; 22: 738-748.
- 30. van Gelder T. European Society for Organ Transplantation Advisory Committee recommendations on generic substitution of immunosuppressive drugs. Transpl Int. 2011; 24: 1135-1141.
- 31. Minogue B. The two fundamental duties of the physician. Acad Med. 2000; 75: 431-442.
- 32. Maynard A. Health care rationing: doing it better in public and private health care systems. J Health Polit Policy Law. 2013; 38: 1103-1127.
- 33. Devaney A, Lee M. The use of generic immunosuppression for transplant patients: a UK perspective. Eur J Hosp Pharm. 2013; 20: 272-274.
Language: English
Page range: 133 - 138
Published on: Dec 30, 2015
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2015 Goce Spasovski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.